B. J. Morris
University of Sydney
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by B. J. Morris.
Clinical and Experimental Pharmacology and Physiology | 1996
Lr Friend; B. J. Morris; Philip Thomas Gaffney; Lyn R. Griffiths
1. Nitric oxide synthase and renal kallikrein are both involved in blood pressure regulation. Genes for these enzymes may, therefore, be considered candidates for hypertension pathogenesis.
Clinical and Experimental Pharmacology and Physiology | 1996
B. J. Morris; Susan M. Chambers
1. A missense mutation leading to reduced ligand affinity in the glucagon receptor (GCG‐R) has been found recently to be five‐fold more common in essential hypertensives than normotensives. The present paper provides additional information on patients that harbour this variant and proposes a possible mechanism by which this may lead to hypertension.
International Journal of Obesity | 1997
Sue Rutherford; Dale R. Nyholt; Robert P. Curtain; Quinlan; Philip Thomas Gaffney; B. J. Morris; Lyn R. Griffiths
OBJECTIVE: To determine whether a microsatellite polymorphism located towards the 3’ end of the low density lipoprotein receptor gene (LDLR) is associated with obesity. DESIGN: A cross-sectional case-control study. SUBJECTS: One hundred and seven obese individuals, defined as a body mass index (BMI)≥26 kg/m2, and 163 lean individuals, defined as a BMI<26 kg/m2. MEASUREMENTS: BMI, blood pressure, serum lipids, alleles of LDLR microsatellite (106 bp, 108 bp and 112 bp). RESULTS: There was a significant association between variants of the LDLR microsatellite and obesity, in the overall tested population, due to a contributing effect in females (χ2=12.3, P=0.002), but not in males (χ2=0.3, P=0.87). In females, individuals with the 106 bp allele were more likely to be lean, while individuals with the 112 bp and/or 108 bp alleles tended to be obese. CONCLUSIONS: These results suggest that in females, LDLR may play a role in the development of obesity.
Clinical and Experimental Pharmacology and Physiology | 1998
Sue Rutherford; Sd Boatwright; Ga Samwell; B. J. Morris; Lyn R. Griffiths
1. Previous glucagon receptor gene (GCGR) studies have shown a Gly40Ser mutation to be more prevalent in essential hypertension and to affect glucagon binding affinity to its receptor. An Alu‐repeat poly(A) polymorphism colocalized to GCGR was used in the present study to test for association and linkage in hypertension as well as association in obesity development.
Clinical and Experimental Pharmacology and Physiology | 1986
B. J. Morris; Daniel F. Catanzaro
1. New gene data for three aspartyl proteases (human renin, mouse renin and human pepsin) permitted closer analysis of the gene duplication and fusion hypothesis for the evolution of this family of enzymes.
Journal of Medical Virology | 1989
Peter B. Dallas; Judith L. Flanagan; Brain N. Nightingale; B. J. Morris
Hypertension | 1997
B. J. Morris; Jeyasingam Cl; Weihua Zhang; Robert P. Curtain; Lyn R. Griffiths
Institute of Health and Biomedical Innovation | 1998
B. J. Morris; Lyn R. Griffiths
Institute of Health and Biomedical Innovation | 1993
L.-H. Ying; Robert Y.L. Zee; Lyn R. Griffiths; B. J. Morris
Institute of Health and Biomedical Innovation | 1993
B. J. Morris; Robert Y.L. Zee; L.-H. Ying; Lyn R. Griffiths